AdvanSix (ASIX -4.62%), a U.S.-based producer of essential chemicals, released results on August 1, 2025, covering the three months ended June 30. The headline was a mixed performance: adjusted diluted earnings per share (Non-GAAP) came in at $1.24, beating the $1.185 analyst estimate by 4.6%, but revenue (GAAP) of $410 million missed expectations, coming in 4.3% below the $428.4 million GAAP consensus. Compared to Q2 2024, revenue (GAAP) slipped 9.6%, and adjusted EBITDA (non-GAAP) dropped 28.8% versus Q2 ...